CN114028327B - Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof - Google Patents
Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof Download PDFInfo
- Publication number
- CN114028327B CN114028327B CN202111604119.6A CN202111604119A CN114028327B CN 114028327 B CN114028327 B CN 114028327B CN 202111604119 A CN202111604119 A CN 202111604119A CN 114028327 B CN114028327 B CN 114028327B
- Authority
- CN
- China
- Prior art keywords
- extract
- strontium chloride
- ectoin
- antibacterial gel
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 80
- 229910001631 strontium chloride Inorganic materials 0.000 title claims abstract description 64
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 title claims abstract description 64
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 title claims abstract description 60
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 114
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 41
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 38
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 38
- 229960003321 baicalin Drugs 0.000 claims abstract description 38
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 33
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 33
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 32
- 229960001631 carbomer Drugs 0.000 claims abstract description 32
- 239000008367 deionised water Substances 0.000 claims abstract description 19
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 19
- 238000011282 treatment Methods 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 15
- 206010042674 Swelling Diseases 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000008961 swelling Effects 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 11
- 210000000214 mouth Anatomy 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 230000003239 periodontal effect Effects 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 208000005888 Periodontal Pocket Diseases 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002324 mouth wash Substances 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 241000894006 Bacteria Species 0.000 abstract description 14
- 201000001245 periodontitis Diseases 0.000 abstract description 14
- 230000008439 repair process Effects 0.000 abstract description 14
- 210000000963 osteoblast Anatomy 0.000 abstract description 12
- 206010061218 Inflammation Diseases 0.000 abstract description 10
- 230000004054 inflammatory process Effects 0.000 abstract description 10
- 206010061363 Skeletal injury Diseases 0.000 abstract description 8
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 6
- 230000005779 cell damage Effects 0.000 abstract description 5
- 208000037887 cell injury Diseases 0.000 abstract description 5
- 201000002170 dentin sensitivity Diseases 0.000 abstract description 5
- 208000014674 injury Diseases 0.000 abstract description 5
- 230000003405 preventing effect Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 230000036347 tooth sensitivity Effects 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 230000003115 biocidal effect Effects 0.000 abstract description 4
- 230000009982 effect on human Effects 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 238000007790 scraping Methods 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 210000004195 gingiva Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- -1 luteolin glycoside Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000002379 periodontal ligament Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 159000000008 strontium salts Chemical class 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- FTBBGQKRYUTLMP-UHFFFAOYSA-N 2-nitro-1h-pyrrole Chemical class [O-][N+](=O)C1=CC=CN1 FTBBGQKRYUTLMP-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000003433 Gingival Pocket Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000001143 Periodontal Abscess Diseases 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 206010067268 Post procedural infection Diseases 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 208000008010 Tooth Avulsion Diseases 0.000 description 1
- 206010044016 Tooth abscess Diseases 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 208000034391 chronic adult periodontitis Diseases 0.000 description 1
- 208000001277 chronic periodontitis Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000007406 plaque accumulation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride, and a preparation method and a use method thereof, wherein the effective components of the antibacterial gel comprise baicalin extract, honeysuckle extract, pseudo-ginseng extract, ectoin and strontium chloride; and the mass percentage of each component is as follows: 1 to 3 percent of ectoin, 1 to 5 percent of strontium chloride, 1 to 5 percent of baicalin extract, 1 to 7 percent of honeysuckle extract, 1 to 5 percent of pseudo-ginseng extract, 0.5 to 1 percent of carbomer and the balance of deionized water. The invention takes the Chinese herbal medicine components as the main components, does not contain any antibiotic components, does not cause periodontitis bacteria to generate drug resistance, and has no side effect on human bodies; the antibacterial gel can promote the repair of alveolar bone injury by adding the ectoin and the strontium chloride, reduce the osteoblast injury under the synergistic effect of the ectoin and the strontium chloride, and promote the activity of the osteoblast, so that the aims of promoting the repair of the alveolar bone injury, reducing cell injury and inflammatory reaction and preventing tooth sensitivity are fulfilled, and the antibacterial gel has good application value.
Description
Technical Field
The invention relates to an oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and a preparation method and a use method thereof.
Background
Common telephone speaking people take food as the day and take teeth as the first, and along with the improvement of the living standard of people, the oral hygiene and the health are also more and more paid attention to. Plaque accumulated in the gingival and dental junction and harmful substances therein act on the gingiva for a long time to cause inflammation, and the presence of plaque, bad restorations, food impaction, tooth dislocation crowding, mouth breathing and the like aggravates plaque accumulation and inflammation of the gingiva to cause gingivitis. If gingivitis is not treated in time, the inflammation can be diffused from the gingiva to the deep layer to periodontal ligament, alveolar bone and cementum to develop into periodontitis, and due to the expansion of the inflammation, the periodontal ligament is destroyed, the alveolar bone is gradually absorbed, the gingiva is separated from the tooth root, so that a gingival sulcus is deepened to form a periodontal pocket, periodontal tissues are destroyed, especially when the absorption of the alveolar bone is aggravated, the supporting tooth strength is insufficient, phenomena such as loosening and displacement of teeth occur, and when the body resistance is reduced and the seepage and drainage of the periodontal pocket are not smooth, periodontal abscess can be formed. In addition, when a patient performs corresponding oral treatment such as scaling, scraping and periodontal surgery, oral bacteria are particularly important in antibacterial care because oral microorganisms widely exist in dental plaque, oral mucosa, dental calculus, gingival pocket, saliva and dental pulp after operation, and easily enter wounds to cause dental plaque and bacterial infection.
At present, the oral care gel products on the market mostly achieve the antibacterial and anti-inflammatory effects by adding antibiotics such as nitroazoles, imidazole derivatives, tetracyclines and the like. For example, the dental implant oral care gel disclosed in Chinese patent document CN110856702A can inhibit dental plaque by adding imidazoline, so as to reduce postoperative infection; another method for synthesizing gel patch preparation for treating periodontitis disclosed in chinese patent document CN111358770a kills porphyromonas gingivalis, praecox intermedia, etc. by adding metronidazole. These methods can effectively kill periodontitis bacteria, but long-term use of the product can easily cause the periodontitis bacteria to generate antibiotic resistance, and can also generate corresponding side effects on human bodies. Moreover, none of these products can repair alveolar bone, which is damaged when periodontal pocket formation occurs as described above, although the existing oral care gel products can kill periodontitis bacteria, however, alveolar bone damage still exists, oral microorganisms widely exist, periodontitis is re-initiated when body resistance is reduced, gingivitis is repeated, and complete healing cannot be achieved.
Disclosure of Invention
Aiming at the problems, the invention provides the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride and the application method thereof, which adopts traditional Chinese medicine components such as honeysuckle extract, pseudo-ginseng extract, baicalin extract and the like to be compatible, and the ectoin and the strontium chloride are added, so that the purposes of antibacterial, anti-inflammatory and repairing alveolar bones and mucous membranes are effectively achieved, drug resistance is not generated, and the oral traditional Chinese medicine antibacterial gel is beneficial to human health. The specific technical scheme is as follows:
firstly, the invention provides an oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride, wherein the effective components of the antibacterial gel comprise baicalin extract, honeysuckle extract, pseudo-ginseng extract, ectoin and strontium chloride.
The oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride comprises the following components in percentage by mass: 1 to 3 percent of ectoin, 1 to 5 percent of strontium chloride, 1 to 5 percent of baicalin extract, 1 to 7 percent of honeysuckle extract, 1 to 5 percent of pseudo-ginseng extract, 0.5 to 1 percent of carbomer and the balance of deionized water.
Preferably, the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride comprises the following components in percentage by mass: the content of the escidodine is preferably 1-2%, the content of the strontium chloride is preferably 1-2%, the content of the baical skullcap root is preferably 2-3%, the content of the honeysuckle is preferably 2-5%, the content of the sanchi is preferably 2-3%, and the content of the carbomer is preferably 0.5-0.7%.
Secondly, the invention provides a preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, which comprises the following steps:
1) Preparing a traditional Chinese medicine extract: preparing baicalin extract, honeysuckle extract and pseudo-ginseng extract according to the requirements respectively for standby;
2) Preparation of an effective component A: weighing the prepared baicalin extract, the honeysuckle extract and the pseudo-ginseng extract according to the weight percentage, and stirring in a proper amount of deionized water until the baicalin extract, the honeysuckle extract and the pseudo-ginseng extract are completely dissolved to obtain an effective component A for later use;
3) Preparation of an effective component B: weighing the ectoin and the strontium chloride according to the weight percentage, and stirring in a proper amount of deionized water until the ectoin and the strontium chloride are completely dissolved to obtain an effective component B for later use;
4) Preparation of carbomer swellings: weighing the carbomer raw material according to the weight percentage, dissolving the carbomer raw material in the balance deionized water, and adding a certain amount of NaOH to adjust the pH to 6-8 to obtain a carbomer swelling material for standby;
5) Preparing antibacterial gel: adding the prepared active component A into the prepared carbomer swelling material, stirring until gel is formed, adding the prepared active component B, and uniformly mixing to obtain the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride.
As a preferred technical scheme, in the preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride in step 1), the preparation method of the baicalin extract is as follows: removing fibrous roots and sediment from the dried root of scutellaria baicalensis, removing coarse skin, crushing, scalding the raw materials with 10 times of boiling water for 2 hours after the raw materials are put into a tank, decocting the raw materials with 8 times of water for 1 hour each time respectively for the second and third times, merging decoction, concentrating to a proper amount, regulating the pH value to 1.0-2.0 by using hydrochloric acid, preserving heat at 80 ℃, standing, filtering, precipitating, washing with water to about pH value 5.0, washing with 70% ethanol to about pH value 7.0, drying at low temperature, volatilizing ethanol, and drying under reduced pressure to obtain a baicalin extract finished product.
As a preferred technical scheme, in the preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride in step 1), the preparation method of the honeysuckle extract is as follows: cutting dried honeysuckle into segments, firstly using 10 times of water to decoct for 2 hours, filtering, then using 8 times of water to decoct for 2 hours again, filtering, combining filtrate, concentrating under reduced pressure, and drying the concentrated solution under reduced pressure to obtain the honeysuckle extract.
As a preferred technical scheme, in the preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride in step 1), the preparation method of the pseudo-ginseng extract is as follows: pulverizing dried root of notoginseng, adding 5-8 times of 70% ethanol, extracting for 2-3 h, collecting filtrate, concentrating under reduced pressure to obtain concentrated solution, and spray drying to obtain notoginseng extract.
As a preferable technical scheme, in the preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, in the step 2), the stirring time for preparing the effective component A is 1-2 h.
As a preferable technical scheme, in the preparation method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, in the step 3), the stirring time for preparing the effective component B is 20-30 min.
In addition, the invention also provides a use method of the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, which specifically comprises the following steps: injecting the antibacterial gel coating film into a periodontal pocket of a gingival sulcus treatment area after conventional periodontal treatment operation, so that the antibacterial gel coating film wraps teeth until slightly overflows; no food, no water, no mouth rinse within 30 minutes; is used once daily for 7 days as a treatment course.
The beneficial effects of the invention are as follows:
(1) The antibacterial gel disclosed by the invention mainly contains Chinese herbal medicine components, does not contain any antibiotic components, does not cause periodontitis bacteria to generate drug resistance, and has no side effect on human bodies.
(2) According to the antibacterial gel disclosed by the invention, the addition of the ectoin and the strontium chloride can promote the repair of alveolar bone injury, wherein the ectoin can form a protective layer around cells, so that the cell injury is effectively reduced, osteoblasts are protected, the strontium chloride can promote the activity of the osteoblasts, the proliferation of the osteoblasts is increased, and under the synergistic effect of the ectoin and the strontium chloride, the activity of the osteoblasts is promoted while the injury of the osteoblasts is reduced, so that the purposes of promoting the repair of the alveolar bone injury, reducing the cell injury and inflammatory response and preventing tooth sensitivity are achieved.
(3) The antibacterial gel disclosed by the invention has the effects of inhibiting bacteria and diminishing inflammation and preventing and treating swelling and pain after being treated by adding the baicalin extract and the honeysuckle extract; the pseudo-ginseng extract is added to help the gum to stop bleeding and accelerate the healing of mucous membrane; the combination of the ectoin and the strontium chloride promotes the injury repair effect of the alveolar bone, achieves the purpose of one-step treatment and repair, and solves the problem that periodontitis is repeatedly difficult to cure.
(4) The preparation method of the antibacterial gel of the invention concentrates the baicalin extract to improve the antibacterial effect; the concentrated solution of the honeysuckle extract is decompressed and dried, so that pharmacological active ingredients such as chlorogenic acid, luteolin glycoside and the like of the concentrated solution are reserved to the maximum extent, and the inhibition of the concentrated solution on periodontitis bacteria is ensured; the concentrated solution of the pseudo-ginseng extract adopts spray drying to ensure the activity of components such as saponins, polysaccharides, flavonoids, alkynes, alcohols and the like, and ensure that the components can induce platelets to release hemostatic active substances such as ADP, platelet factors, ca2+, and the like, and promote only coagulation and oral mucosa repair.
(5) According to the preparation method of the antibacterial gel, the ectoine, the strontium chloride, the honeysuckle extract, the pseudo-ginseng extract and the baicalin extract are prepared separately and then sequentially added into the carbomer swelling material, so that the problem that the effective components cannot be uniformly dispersed and dissolved due to the fact that the strontium salt reacts with flavonoid and other components in the honeysuckle extract, the pseudo-ginseng extract and the baicalin extract and the effective components are directly mixed with the carbomer is effectively avoided.
(6) The antibacterial gel prepared by the invention has wide application range, and can be suitable for antibacterial and anti-inflammatory treatment of corresponding oral cavity treatments such as cleaning, scraping treatment, periodontal surgery and the like, and can also be suitable for relieving the problem of tooth sensitivity after tooth washing, tooth whitening and the like.
Drawings
FIG. 1 shows the indexes of the antibacterial gel before administration;
FIG. 2 shows the indexes observed 3 days after the antibacterial gel is used for medicine;
fig. 3 shows the indexes observed 7 days after administration of the antibacterial gel.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be clearly and completely described below with reference to the embodiments.
Example 1
The embodiment is to prepare an oral traditional Chinese medicine antibacterial gel containing ectoine and strontium chloride, wherein the antibacterial gel comprises the following components in percentage by mass: 3% of ectoin, 4% of strontium chloride, 2% of baicalin extract, 2% of honeysuckle extract, 1% of pseudo-ginseng extract, 1% of carbomer and the balance of deionized water. The preparation method comprises the following specific steps:
1) Preparing a traditional Chinese medicine extract: preparing baicalin extract, flos Lonicerae extract and Notoginseng radix extract respectively according to requirements. Wherein,,
the preparation method of the baicalin extract comprises the following steps: removing fibrous roots and sediment from the dried root of scutellaria baicalensis, removing coarse skin, crushing, scalding the raw materials with 10 times of boiling water for 2 hours after the raw materials are put into a tank, decocting the raw materials with 8 times of water for 1 hour each time respectively for the second and third times, merging decoction, concentrating to a proper amount, regulating the pH value to 1.0-2.0 by using hydrochloric acid, preserving heat at 80 ℃, standing, filtering, precipitating, washing with water to about pH value 5.0, washing with 70% ethanol to about pH value 7.0, drying at low temperature, volatilizing ethanol, and drying under reduced pressure to obtain a baicalin extract finished product.
The preparation method of the honeysuckle extract comprises the following steps: cutting dried honeysuckle into segments, firstly using 10 times of water to decoct for 2 hours, filtering, then using 8 times of water to decoct for 2 hours again, filtering, combining filtrate, concentrating under reduced pressure, and drying the concentrated solution under reduced pressure to obtain the honeysuckle extract.
The preparation method of the pseudo-ginseng extract comprises the following steps: pulverizing dried root of notoginseng, adding 5-8 times of 70% ethanol, extracting for 2-3 h, collecting filtrate, concentrating under reduced pressure to obtain concentrated solution, and spray drying to obtain notoginseng extract.
2) Preparation of an effective component A: the baicalin extract, the honeysuckle extract and the pseudo-ginseng extract which are prepared by weighing according to the weight percentage are dissolved in a proper amount of deionized water and stirred for 1-2 hours until the baicalin extract, the honeysuckle extract and the pseudo-ginseng extract are completely dissolved, and an effective component A is obtained for standby.
3) Preparation of an effective component B: weighing the ectoin and the strontium chloride according to the weight percentage, dissolving the ectoin and the strontium chloride in a proper amount of deionized water, and stirring for 20-30 min until the ectoin and the strontium chloride are completely dissolved, thus obtaining an effective component B for standby.
4) Preparation of carbomer swellings: and weighing the carbomer raw materials according to the weight percentage, dissolving the carbomer raw materials in the rest deionized water, taking the condition that white powder cannot be seen on the surface and white aggregate cannot be seen in the solution as a reference, and adding a certain amount of NaOH to adjust the pH to 6-8 to obtain the carbomer swelled material for standby.
5) Preparing antibacterial gel: adding the prepared active component A into the prepared carbomer swelling material, stirring until gel is formed, adding the prepared active component B, and uniformly mixing to obtain the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride.
Example 2
The embodiment also prepares a traditional Chinese medicine antibacterial gel for oral cavity containing ectoin and strontium chloride, and the antibacterial gel comprises the following components in percentage by mass: 2% of ectoin, 2% of strontium chloride, 3% of baicalin, 5% of honeysuckle extract, 3% of pseudo-ginseng extract, 0.7% of carbomer and the balance of deionized water. The specific preparation method is the same as in example 1.
Example 3
The embodiment also prepares a traditional Chinese medicine antibacterial gel for oral cavity containing ectoin and strontium chloride, and the antibacterial gel comprises the following components in percentage by mass: 1% of ectoine, 1% of strontium chloride, 5% of baicalin, 7% of honeysuckle extract, 5% of pseudo-ginseng extract, 0.5% of carbomer and the balance of deionized water. The specific preparation method is the same as in example 1.
Effect example
In order to verify the synergistic effect of the ectoin and the strontium chloride to promote the repair of alveolar bone injury, and the effects of inhibiting bacteria, diminishing inflammation, helping to stop bleeding of gums and accelerating healing of mucous membranes of the traditional Chinese medicine extract components. The embodiment adopts a comparative example mode for verification, and the specific verification method is as follows:
first, this example provides three sets of comparative examples, and provides a blank, wherein:
comparative example 1: the prepared antibacterial gel for oral cavity traditional Chinese medicine comprises the following components in percentage by mass: 2% of baicalin, 2% of honeysuckle extract, 1% of pseudo-ginseng extract, 1% of carbomer and the balance of deionized water. The specific preparation method is the same as in example 1.
Comparative example 2: the prepared antibacterial gel for oral cavity traditional Chinese medicine comprises the following components in percentage by mass: strontium chloride 4%, baicalin 2%, honeysuckle extract 2%, pseudo-ginseng extract 1%, carbomer 1% and the balance of deionized water. The specific preparation method is the same as in example 1.
Comparative example 3: the prepared antibacterial gel for oral cavity traditional Chinese medicine comprises the following components in percentage by mass: 3% of ectoin, 2% of baicalin, 2% of honeysuckle extract, 1% of pseudo-ginseng extract, 1% of carbomer and the balance of deionized water. The specific preparation method is the same as in example 1.
The components and the contents of the oral traditional Chinese medicine antibacterial gel prepared in each comparative example, comparative example and example are shown in table 1.
TABLE 1 oral antibacterial gel products for each group
Component (A) | Blank control group | Comparative example 1 | Comparative example 2 | Comparative example 3 | Example 1 | Example 2 | Example 3 |
Ikeduoyin | 0 | -- | -- | 3% | 3% | 2% | 1% |
Strontium chloride | 0 | -- | 4% | -- | 4% | 2% | 1% |
Baicalin extract | 0 | 2% | 2% | 2% | 2% | 3% | 5% |
Honeysuckle extract | 0 | 2% | 2% | 2% | 2% | 7% | 7% |
Notoginseng radix extract | 0 | 1% | 1% | 1% | 1% | 5% | 5% |
Carbomer (carbomer) | 0 | 1% | 1% | 1% | 1% | 0.7% | 0.5% |
Deionized water | 0 | 94% | 90% | 91% | 87% | 80.3% | 80.5% |
Physiological saline | 100% | 0 | 0 | 0 | 0 | 0 | 0 |
The experimental method comprises the following steps: in order to ensure the true effectiveness of the effect, 140 adult periodontitis patients are selected as study objects in the experiment, and the ages of the patients are as follows: the animals were 18-60 years old and were equally divided into experimental, control and blank groups at random. The blank control group is used for conventional periodontal cleaning and scraping treatment, and is washed by conventional normal saline after operation. The experimental group carried out conventional periodontal scaling and scraping treatment, and the oral antibacterial gel product prepared in examples 1-3 was used after operation, and the coating film was injected into gingival sulcus and periodontal pocket in the treatment area to wrap the teeth until slightly overflowing. No food, no water, no mouth rinse within 30 minutes. Is used once daily. The comparative group was treated in exactly the same manner as the experimental group except that the oral antibacterial gel products prepared in comparative examples 1 to 3 were used. The component contents of the oral antibacterial gel products used in each group are shown in table 1. The Gingival Index (GI), plaque index (PLI), gingival crevicular bleeding index (SBI) and depth of investigation (PD) were observed and counted for the patient before treatment, 3 days after treatment, and 7 days after treatment, respectively.
Experimental results: the two groups of observations before and after the treatment are shown in tables 2, 3 and 4 and figures 1 to 3.
TABLE 2 observation index before administration
Index (I) | Blank control group | Control group 1 | Control group 2 | Control group 3 | Experiment group 1 | Experiment group 2 | Experiment group 3 |
GI | 1.93±0.27 | 1.92±0.35 | 1.93±0.24 | 1.95±0.37 | 1.95±0.55 | 1.92±0.53 | 1.95±0.52 |
PLI | 2.11±0.15 | 2.08±0.29 | 2.10±0.11 | 2.05±0.20 | 2.02±0.31 | 2.06±0.37 | 2.10±0.11 |
SBI | 3.08±0.30 | 3.14±0.25 | 3.20±0.35 | 3.05±0.31 | 3.17±0.47 | 3.29±0.37 | 3.10±0.35 |
PD | 5.01±0.97 | 4.95±0.86 | 5.13±0.62 | 4.96±0.59 | 4.98±1.01 | 5.03±0.88 | 4.98±0.92 |
TABLE 3 observation index 3 days after administration
Index (I) | Blank control group | Control group 1 | Control group 2 | Control group 3 | Experiment group 1 | Experiment group 2 | Experiment group 3 |
GI | 1.61±0.39 | 1.12±0.33 | 1.09±0.52 | 1.11±0.38 | 1.02±0.34 | 1.12±0.55 | 1.05±0.39 |
PLI | 1.76±0.39 | 1.25±0.31 | 1.17±0.35 | 1.20±0.36 | 1.13±0.19 | 1.16±0.42 | 1.10±0.53 |
SBI | 1.97±0.51 | 1.44±0.35 | 1.41±0.40 | 1.45±0.53 | 1.40±0.36 | 1.42±0.34 | 1.46±0.38 |
PD | 4.62±0.93 | 4.65±0.71 | 4.50±0.51 | 4.54±0.50 | 4.33±0.91 | 4.35±0.70 | 4.38±0.62 |
TABLE 4 observation index 7 days after administration
Index (I) | Blank control group | Control group 1 | Control group 2 | Control group 3 | Experiment group 1 | Experiment group 2 | Experiment group 3 |
GI | 0.98±0.62 | 0.65±0.37 | 0.58±0.21 | 0.62±0.35 | 0.53±0.52 | 0.59±0.41 | 0.65±0.48 |
PLI | 1.13±0.39 | 0.88±0.26 | 0.84±0.31 | 0.85±0.20 | 0.79±0.28 | 0.86±0.33 | 0.83±0.42 |
SBI | 0.70±0.48 | 0.31±0.29 | 0.27±0.33 | 0.30±0.51 | 0.28±0.29 | 0.31±0.54 | 0.30±0.41 |
PD | 4.31±0.90 | 4.32±0.53 | 4.10±0.71 | 4.16±0.64 | 3.87±0.89 | 3.90±0.58 | 3.88±0.67 |
Each observation index of the experimental group and the control group is processed by SPSS software, and is statistically processed by t test, and the comparison of the two groups has significant difference P less than 0.05. The test result shows that the antibacterial gel for oral cavity can obtain better clinical effect when being applied to adjuvant therapy of periodontitis, and can effectively inhibit bacteria, diminish inflammation and stop bleeding and recover.
Meanwhile, fig. 1 to 3 also show that the index of the control group GI, PLI, SBI is obviously better than that of the control group compared with the recovery condition of the control group before and after the administration for 3 days, so that the traditional Chinese medicine extract components in the antibacterial gel for oral cavity can achieve the effects of inhibiting bacteria, diminishing inflammation, helping gum hemostasis and accelerating mucous membrane healing. The PD index of the experimental group is smaller than that of the control group by comparing the recovery condition of the control group and the experimental group before and after the administration for 7 days, which shows that the repairing of the alveolar bone injury can be promoted to a certain extent under the synergistic effect of the ectoin and the strontium chloride.
In general, the antibacterial gel disclosed by the invention mainly contains Chinese herbal medicine components, does not contain any antibiotic components, does not cause periodontitis bacteria to generate drug resistance, and has no side effect on human bodies. According to the antibacterial gel disclosed by the invention, the addition of the ectoin and the strontium chloride can promote the repair of alveolar bone injury, wherein the ectoin can form a protective layer around cells, so that the cell injury is effectively reduced, osteoblasts are protected, the strontium chloride can promote the activity of the osteoblasts, the proliferation of the osteoblasts is increased, and under the synergistic effect of the ectoin and the strontium chloride, the activity of the osteoblasts is promoted while the injury of the osteoblasts is reduced, so that the purposes of promoting the repair of the alveolar bone injury, reducing the cell injury and inflammatory response and preventing tooth sensitivity are achieved. The antibacterial gel disclosed by the invention has the effects of inhibiting bacteria and diminishing inflammation and preventing and treating swelling and pain after being treated by adding the baicalin extract and the honeysuckle extract; the pseudo-ginseng extract is added to help the gum to stop bleeding and accelerate the healing of mucous membrane; the combination of the ectoin and the strontium chloride promotes the injury repair effect of the alveolar bone, achieves the purpose of one-step treatment and repair, and solves the problem that periodontitis is repeatedly difficult to cure. The preparation method of the antibacterial gel of the invention concentrates the baicalin extract to improve the antibacterial effect; the concentrated solution of the honeysuckle extract is decompressed and dried, so that pharmacological active ingredients such as chlorogenic acid, luteolin glycoside and the like of the concentrated solution are reserved to the maximum extent, and the inhibition of the concentrated solution on periodontitis bacteria is ensured; the concentrated solution of the pseudo-ginseng extract adopts spray drying to ensure the activity of components such as saponins, polysaccharides, flavonoids, alkynes, alcohols and the like, ensure that platelets can be induced to release hemostatic active substances such as ADP, platelet factors, ca2+, and the like, and promote blood coagulation and oral mucosa repair. According to the preparation method of the antibacterial gel, the ectoine, the strontium chloride, the honeysuckle extract, the pseudo-ginseng extract and the baicalin extract are prepared separately and then sequentially added into the carbomer swelling material, so that the problem that the effective components cannot be uniformly dispersed and dissolved due to the fact that the strontium salt reacts with flavonoid and other components in the honeysuckle extract, the pseudo-ginseng extract and the baicalin extract and the effective components are directly mixed with the carbomer is effectively avoided. The antibacterial gel prepared by the invention has wide application range, can be suitable for antibacterial and anti-inflammatory treatment of corresponding oral cavity such as cleaning, scraping and periodontal surgery, can also be suitable for relieving the problem of tooth sensitivity after tooth washing and tooth whitening, and has good application value.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. Accordingly, the embodiments are to be considered in all respects as illustrative and not restrictive. Furthermore, it should be understood that, although the present disclosure describes embodiments, this description is not intended to include only one embodiment, and those skilled in the art should understand that the present disclosure is not limited to the embodiments described herein, and that the embodiments described in the examples may be combined appropriately to form other embodiments that will be understood by those skilled in the art.
Claims (8)
1. An oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride is characterized in that: the active ingredients of the antibacterial gel comprise baicalin extract, honeysuckle extract, pseudo-ginseng extract, ectoin and strontium chloride; wherein:
the preparation method of the honeysuckle extract comprises the following steps: cutting dried honeysuckle into segments, firstly decocting with 10 times of water for 2 hours, filtering, then decocting with 8 times of water for 2 hours again, filtering, combining filtrates, concentrating under reduced pressure, and drying the concentrate under reduced pressure to obtain a honeysuckle extract;
the preparation method of the pseudo-ginseng extract comprises the following steps: pulverizing dried root of notoginseng, adding 5-8 times of 70% ethanol, extracting for 2-3 h, collecting filtrate, concentrating under reduced pressure to obtain concentrated solution, and spray drying to obtain notoginseng extract.
2. The antibacterial gel for oral cavity containing ectoin and strontium chloride according to claim 1, wherein the antibacterial gel is characterized in that: the antibacterial gel comprises the following components in percentage by mass: 1 to 3 percent of ectoin, 1 to 5 percent of strontium chloride, 1 to 5 percent of baicalin extract, 1 to 7 percent of honeysuckle extract, 1 to 5 percent of pseudo-ginseng extract, 0.5 to 1 percent of carbomer and the balance of deionized water.
3. The antibacterial gel for oral use containing exendin and strontium chloride according to claim 2, wherein: the antibacterial gel comprises the following components in percentage by mass: 1-2% of ectoin, 1-2% of strontium chloride, 2-3% of baicalin extract, 2-5% of honeysuckle extract, 2-3% of pseudo-ginseng extract and 0.5-0.7% of carbomer.
4. A method for preparing the antibacterial gel containing the exendin and the strontium chloride for oral use according to claim 2 or 3, which is characterized in that: the method comprises the following steps:
1) Preparing a traditional Chinese medicine extract: preparing baicalin extract, honeysuckle extract and pseudo-ginseng extract according to the requirements respectively for standby;
2) Preparation of an effective component A: weighing the prepared baicalin extract, the honeysuckle extract and the pseudo-ginseng extract according to the weight percentage, and stirring in a proper amount of deionized water until the baicalin extract, the honeysuckle extract and the pseudo-ginseng extract are completely dissolved to obtain an effective component A for later use;
3) Preparation of an effective component B: weighing the ectoin and the strontium chloride according to the weight percentage, and stirring in a proper amount of deionized water until the ectoin and the strontium chloride are completely dissolved to obtain an effective component B for later use;
4) Preparation of carbomer swellings: weighing the carbomer raw material according to the weight percentage, dissolving the carbomer raw material in the balance deionized water, and adding a certain amount of NaOH to adjust the pH to 6-8 to obtain a carbomer swelling material for later use;
5) Preparing antibacterial gel: adding the prepared active component A into the prepared carbomer swelling material, stirring until gel is formed, adding the prepared active component B, and uniformly mixing to obtain the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride.
5. The method for preparing the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, which is disclosed in claim 4, is characterized in that: in the step 1), the preparation method of the baicalin extract comprises the following steps: removing fibrous roots and sediment from the dried root of scutellaria baicalensis, removing coarse skin, crushing, scalding the raw materials with 10 times of boiling water for 2 hours after the raw materials are put into a tank, decocting the raw materials with 8 times of water for 1 hour each time respectively for the second and third times, merging decoction, concentrating to a proper amount, regulating the pH value to 1.0-2.0 by using hydrochloric acid, preserving heat at 80 ℃, standing, filtering, precipitating, washing with water to about pH value 5.0, washing with 70% ethanol to about pH value 7.0, drying at low temperature, volatilizing ethanol, and drying under reduced pressure to obtain a baicalin extract finished product.
6. The method for preparing the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, which is disclosed in claim 4, is characterized in that: in the step 2), the stirring time for preparing the effective component A is 1-2 h.
7. The method for preparing the oral traditional Chinese medicine antibacterial gel containing the ectoin and the strontium chloride, which is disclosed in claim 4, is characterized in that: in the step 3), the stirring time for preparing the effective component B is 20-30 min.
8. Use of an oral traditional Chinese medicine antibacterial gel containing ectoine and strontium chloride according to any one of claims 1-3 for preparing a medicament, characterized in that: the using method comprises the following steps: injecting the antibacterial gel coating film into a periodontal pocket of a gingival sulcus treatment area after conventional periodontal treatment operation, so that the antibacterial gel coating film wraps teeth until slightly overflows; no food, no water, no mouth rinse within 30 minutes; is used once daily for 7 days as a treatment course.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111604119.6A CN114028327B (en) | 2021-12-24 | 2021-12-24 | Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111604119.6A CN114028327B (en) | 2021-12-24 | 2021-12-24 | Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114028327A CN114028327A (en) | 2022-02-11 |
CN114028327B true CN114028327B (en) | 2023-09-12 |
Family
ID=80141236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111604119.6A Active CN114028327B (en) | 2021-12-24 | 2021-12-24 | Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028327B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116327629A (en) * | 2023-02-24 | 2023-06-27 | 华熙生物科技股份有限公司 | Composition with antioxidation effect and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110151594A (en) * | 2019-06-20 | 2019-08-23 | 华熙生物科技股份有限公司 | A kind of oral cavity composition and its application containing Ectoin and hyaluronic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008061535A1 (en) * | 2006-11-21 | 2008-05-29 | Strontin Aps | Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases. |
-
2021
- 2021-12-24 CN CN202111604119.6A patent/CN114028327B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110151594A (en) * | 2019-06-20 | 2019-08-23 | 华熙生物科技股份有限公司 | A kind of oral cavity composition and its application containing Ectoin and hyaluronic acid |
Also Published As
Publication number | Publication date |
---|---|
CN114028327A (en) | 2022-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106580866B (en) | Children's toothpaste | |
Subramaniam et al. | Versatility of aloe vera in dentistry-a review | |
Tayal et al. | Current perspectives on use of Aloe vera in dentistry | |
CN109223663A (en) | A kind of Chinese herbal toothpaste and preparation method thereof for gingivitis | |
Jain et al. | Propolis in oral health: a natural remedy | |
CN109276475A (en) | One kind Chinese medicinal toothpaste containing bletilla polysaccharide and preparation method thereof | |
CN109481527B (en) | Traditional Chinese medicine composition for preventing or treating oral diseases and application thereof | |
CN114028327B (en) | Oral traditional Chinese medicine antibacterial gel containing ectoin and strontium chloride and preparation and application methods thereof | |
Shekhawat et al. | Aloe vera-A miracle plant for dentistry | |
CN113398002B (en) | Desensitizing toothpaste containing modified chitosan and capable of repairing gingiva and preparation process of desensitizing toothpaste | |
CN104825542A (en) | Medical biological tooth desensitizer dressing and preparation method thereof | |
KR102127337B1 (en) | Mouth cleaner comprising medicinal herb extract and manufacturing method thereof | |
Adnan | Clinical effects of commiphora myrrha in oral and dental medicine, a mini review | |
CN101185695B (en) | Externally-applied traditional Chinese medicine for treating toothache | |
CN104258092A (en) | Gargle for treating recurrent aphthous ulcer and periodontitis and preparation method thereof | |
CN112336678B (en) | Toothpaste capable of freshening breath | |
RU2180555C1 (en) | Composition to prevent and treat diseases of mouth cavity and take care of teeth and mouth cavity | |
CN114404522B (en) | Chinese herbal medicine composition, gargle and preparation method | |
Vijay et al. | Local Drug Delivery of Aloe Vera Gel in Chronic Periodontitis Patient. | |
CN115581661A (en) | Compound gargle for preventing and treating oral ulcer and preparation process thereof | |
CN113456708A (en) | Medicine for treating toothache and preparation method thereof | |
CN107412524A (en) | Treat the medicine of decayed tooth | |
CN1395943A (en) | Disinfecting liniment and its preparing process | |
CN114886829A (en) | Toothpaste for treating oral problems and preparation method thereof | |
KR20040063187A (en) | Tooth paste composition contains medicinal herbs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |